JPRN-UMIN000034108Completed未知
The efficacy and safety of Latanoprost ophthalmic solution 0.005% Nitten in Japanese open-angle glaucoma patients - The efficacy and safety of Latanoprost ophthalmic solution 0.005% Nitten in Japanese open-angle glaucoma patients
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
Study Overview
Brief Summary
ot applicable
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 80years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. With a history of eye surgery including laser 2. Having allergy to prostaglandin related drug 3. Using ophthalmic or internal steroids 4. Oral administration of acetazolamide (Diamox) 5. The contact lenses are scheduled to be used during the test period 6. Persons who judged that the doctor in charge is not appropriate
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Safety of Latanoprost EyedropsCTRI/2021/10/037348Aravind Eye Hospital Pondicherry
Completed
Not Applicable
Efficacy of latanoprost (Xalatan) ophthalmic solution stored at room temperatureGlaucoma patientsJPRN-UMIN000000706Hiroshima University Department of Ophthalmology and Visual Science20
Completed
Phase 4
Effect of latanoprost and travoprost ophthalmic solution on corneal epitheliumglaucomaJPRN-UMIN000004000Department of Ophtalmology, University of Tokyo80
Withdrawn
Phase 4
A Study to Evaluate the Effect of Latanoprostene Bunod Ophthalmic Solution 0.024% on Episcleral Venous Pressure and Outflow Facility in Participants With Ocular HypertensionOcular HypertensionNCT04140279Bausch & Lomb Incorporated
Unknown
Phase 4
Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCTGlaucomaOcular HypertensionNCT02585375Medical University of Vienna70